Biocompatibility of a xenogenic elastin-based biomaterial in a murine implantation model: the role of aluminum chloride pretreatment.
We have investigated the long-term effect of aluminum chloride (AlCl(3)) treatment on the calcification and inflammatory reaction of a porcine elastin-derived biomaterial (PEB) in a novel subdermal adult mouse model. Untreated PEB disks and PEB treated with AlCl(3) were implanted subdermally in BALB/c mice for 30, 60, and 180 days. The calcification of the elastin disks was examined with histological analysis and atomic absorption analysis of calcium content. The inflammatory reaction was evaluated both with histological analysis of explants and by an enzyme-linked immunosorbent assay of the serum in each mouse to determine the production of antielastin antibodies. Robust calcification was evident in all untreated PEBs with calcium levels of 107.1 +/- 11.8, 151.4 +/- 14.4, and 227.2 +/- 23.8 microg/mg for 30, 60, and 180 days, respectively. AlCl(3) treatment only temporarily prevented the calcification of the elastin disks for 30 days. By 60 and 180 days, the AlCl(3)-treated materials had significant calcification with 88.7 +/- 17.4 and 105.3 +/- 27.0 microg/mg calcium, respectively. The inflammatory reaction was moderate for both types of implants. The AlCl(3)-treated implants displayed significantly more macrophage and lymphocyte infiltration at 180 days after implantation, and a trend to higher humoral responses at 30 and 60 days when compared with untreated PEBs. We conclude that PEBs extensively calcify in the adult mice model. AlCl(3) treatment of elastin enhances the long-term immunological response to xenogenic elastin implants and merely delays the onset of calcification.
Oregon Medical Laser Center, Providence St. Vincent Medical Center, Portland, Oregon 97225, USA. monica.hinds@bme.ogi.edu
Monica T
MT
Hinds
David W
DW
Courtman
Teresa
T
Goodell
Mason
M
Kwong
Halina
H
Brant-Zawadzki
Allen
A
Burke
Bernard A
BA
Fox
Kenton W
KW
Gregory
D000077410:Aluminum Chloride; D017607:Aluminum Compounds / Q000737:chemistry / Q000494:pharmacology*; D000596:Amino Acids; D000818:Animals; D001011:Aorta / Q000737:chemistry; D001672:Biocompatible Materials / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D002114:Calcinosis / Q000139:chemically induced* / Q000378:metabolism; D002712:Chlorides / Q000737:chemistry / Q000494:pharmacology*; D004195:Disease Models, Animal; D004549:Elastin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D020007:Implants, Experimental; D051379:Mice; D008807:Mice, Inbred BALB C; D011897:Random Allocation; D012867:Skin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013552:Swine
D017607:Aluminum Compounds; D000596:Amino Acids; D001672:Biocompatible Materials; D002712:Chlorides; D000077410:Aluminum Chloride; D004549:Elastin